Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · IEX Real-Time Price · USD
11.08
-0.37 (-3.23%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Cellebrite DI Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Revenue
325.11270.65246.25194.91171.85
Revenue Growth (YoY)
20.12%9.91%26.34%13.42%-
Cost of Revenue
53.2350.7542.5637.8835.82
Gross Profit
271.88219.91203.69157.03136.03
Selling, General & Admin
154.26138.24124.3393.4490.98
Research & Development
84.3980.6265.5454.3846.57
Operating Expenses
238.64218.86189.87147.82137.55
Operating Income
33.241.0413.829.22-1.52
Interest Expense / Income
108.8-119.72-68.48-2.18-2.94
Other Expense / Income
---15.138.16
Pretax Income
-75.56120.7682.31-3.73-6.75
Income Tax
5.54-0.0510.915.623.29
Net Income
-81.1120.8171.4-9.34-10.04
Net Income Growth
-69.20%---
Shares Outstanding (Basic)
190183144124122
Shares Outstanding (Diluted)
190195162124122
Shares Change
-2.68%20.96%30.59%1.76%-
EPS (Basic)
-81100.00116111.0070433.00-0.08-0.08
EPS (Diluted)
-81100.00116111.0070433.00-0.08-0.08
EPS Growth
-64.85%---
Free Cash Flow
94.1411.4927.9460.339.92
Free Cash Flow Per Share
0.490.060.190.490.08
Gross Margin
83.63%81.25%82.72%80.57%79.15%
Operating Margin
10.22%0.39%5.61%4.73%-0.88%
Profit Margin
-24.95%44.63%28.99%-4.79%-5.84%
Free Cash Flow Margin
28.96%4.25%11.35%30.95%5.77%
Effective Tax Rate
--0.04%13.25%--
EBITDA
43.2510.2420.83-0.03-5.6
EBITDA Margin
13.30%3.78%8.46%-0.01%-3.26%
Depreciation & Amortization
10.019.197.015.884.08
EBIT
33.241.0413.82-5.91-9.68
EBIT Margin
10.22%0.39%5.61%-3.03%-5.63%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).